COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 618: Articles 6171-6180  | Next

Demographic and Outcome Characteristics of Children Hospitalized with Acute COVID-19 versus Multisystem Inflammatory Syndrome in Children in Canada
Farrar, D. S., Moore Hepburn, C., Drouin, O., El Tal, T., Morin, M.-P., Berard, R. A., King, M., Laffin Thibodeau, M., Haddad, E., Scuccimarri, R., Yeung, R. S. M., Kakkar, F., Morris, S. K., Canadian Paediatric Surveillance Program COVID-19 Study Team
10.1101/2022.08.18.22278939 — Posted: 2022-08-19
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
Witte, L., Baharani, V., Schmidt, F., Wang, Z., Cho, A., Raspe, R., Guzman-Cardozo, M. C., Muecksch, F., Gaebler, C., Caskey, M., Nussenzweig, M. C., Hatziioannou, T., Bieniasz, P. D.
10.1101/2022.08.17.504313 — Posted: 2022-08-19
Ancestral lineage of SARS-CoV-2 is more stable in human biological fluids than Alpha, Beta and Omicron variants of concern
Kwon, T., Gaudreault, N. N., Meekins, D., McDowell, C., Cool, K., Richt, J. A.
10.1101/2022.08.17.504362 — Posted: 2022-08-19
A syntenin inhibitor blocks endosomal entry of SARS-CoV-2 and a panel of RNA viruses
Lindqvist, R., Benz, C., Sereikaite, V., Maassen, L., Laursen, L., Jemth, P., Stromgaard, K., Ivarsson, Y., Overby, A. K.
10.1101/2022.08.18.504268 — Posted: 2022-08-19
How Have Global Scientists Responded to Tackling COVID-19?
Cao, L., Hou, W.
10.1101/2022.08.16.22278871 — Posted: 2022-08-18
Trends in risk factors and symptoms associated with SARS-CoV-2 and Rhinovirus test positivity in King County, Washington: A Test-Negative Design Study of the Greater Seattle Coronavirus Assessment Network
Hansen, C. L., Perofsky, A., Burstein, R., Famulare, M., Boyle, S., Prentice, R., Marshall, C., McCormick, B. J., Reinhart, D., Capodanno, B., Truong, M., Schwabe-Fry, K., Kuchta, K., Pfau, B., Acker, Z., Lee, J., Sibley, T. R., McDermot, E., Rodriguez-Salas, L., Stone, J., Gamboa, L., Han, P. D., Duchin, J. S., Waghmare, A., Englund, J. A., Shendure, J., Bedford, T., Chu, H. Y., Starita, L. M., Viboud, C.
10.1101/2022.08.12.22278203 — Posted: 2022-08-18
Development and use of a method based on the anti-N reactivity of longitudinal samples to better estimate SARS-CoV-2 seroprevalence in a vaccinated population
Bazin, R., Rochette, S., Perreault, J., Fournier, M.-J., Gregoire, Y., Boivin, A., Lewin, A., Germain, M., Renaud, C.
10.1101/2022.08.15.22278798 — Posted: 2022-08-18
Two years of Covid-19: Excess mortality by age, region, gender, and race/ethnicity in the United States during the Covid-19 pandemic, March 1, 2020, through February 28, 2022
Faust, J. S., Du, C., Renton, B., Liang, C., Chen, A. J., Li, S.-X., Lin, Z., Nunez-Smith, M., Krumholz, H. M.
10.1101/2022.08.16.22278800 — Posted: 2022-08-18
Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis: A Case-Control Cross-sectional and Longitudinal Analysis
Riley, C. S., Venkatesh, S., Dhand, A., Doshi, N. K., Kavak, K., Levit, E. E., Perrone, C., Weinstock-Guttman, B., Longbrake, E. E., MSReCOV Collaborative, , De Jager, P. L., Xia, Z.
10.1101/2022.08.17.22278896 — Posted: 2022-08-18
Uptake of Sotrovimab for prevention of severe COVID-19 and its safety in the community in England
Patone, M., Tibble, H., Snelling, A. J., Coupland, C., Sheikh, A., Hippisley-Cox, J.
10.1101/2022.08.17.22278893 — Posted: 2022-08-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).